Logo image of GORV

LAZYDAYS HOLDINGS INC (GORV) Stock Fundamental Analysis

NASDAQ:GORV - Nasdaq - US52110H1005 - Common Stock - Currency: USD

0.2881  +0.1 (+54.64%)

After market: 0.2377 -0.05 (-17.49%)

Fundamental Rating

2

GORV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. GORV has a bad profitability rating. Also its financial health evaluation is rather negative. GORV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GORV had negative earnings in the past year.
GORV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: GORV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: GORV reported negative operating cash flow in multiple years.
GORV Yearly Net Income VS EBIT VS OCF VS FCFGORV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of GORV (-33.91%) is worse than 90.91% of its industry peers.
GORV's Return On Equity of -215.00% is on the low side compared to the rest of the industry. GORV is outperformed by 80.17% of its industry peers.
Industry RankSector Rank
ROA -33.91%
ROE -215%
ROIC N/A
ROA(3y)-10.85%
ROA(5y)-3.93%
ROE(3y)-96.04%
ROE(5y)-50.53%
ROIC(3y)N/A
ROIC(5y)N/A
GORV Yearly ROA, ROE, ROICGORV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

The Gross Margin of GORV (21.77%) is worse than 79.34% of its industry peers.
GORV's Gross Margin has declined in the last couple of years.
GORV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.14%
GM growth 5Y-2.08%
GORV Yearly Profit, Operating, Gross MarginsGORV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

0

2. Health

2.1 Basic Checks

GORV does not have a ROIC to compare to the WACC, probably because it is not profitable.
GORV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GORV has more shares outstanding
GORV has a worse debt/assets ratio than last year.
GORV Yearly Shares OutstandingGORV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GORV Yearly Total Debt VS Total AssetsGORV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that GORV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GORV (0.87) is worse than 75.21% of its industry peers.
The Debt to FCF ratio of GORV is 8.06, which is on the high side as it means it would take GORV, 8.06 years of fcf income to pay off all of its debts.
GORV's Debt to FCF ratio of 8.06 is in line compared to the rest of the industry. GORV outperforms 52.07% of its industry peers.
A Debt/Equity ratio of 2.87 is on the high side and indicates that GORV has dependencies on debt financing.
The Debt to Equity ratio of GORV (2.87) is worse than 73.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 8.06
Altman-Z 0.87
ROIC/WACCN/A
WACC7.36%
GORV Yearly LT Debt VS Equity VS FCFGORV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

GORV has a Current Ratio of 0.89. This is a bad value and indicates that GORV is not financially healthy enough and could expect problems in meeting its short term obligations.
GORV has a Current ratio of 0.89. This is amonst the worse of the industry: GORV underperforms 80.17% of its industry peers.
GORV has a Quick Ratio of 0.89. This is a bad value and indicates that GORV is not financially healthy enough and could expect problems in meeting its short term obligations.
GORV has a Quick ratio of 0.25. This is amonst the worse of the industry: GORV underperforms 83.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.25
GORV Yearly Current Assets VS Current LiabilitesGORV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

GORV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.82%.
GORV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.50%.
GORV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.21% yearly.
EPS 1Y (TTM)-31.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.48%
Revenue 1Y (TTM)-27.5%
Revenue growth 3Y-10.97%
Revenue growth 5Y6.21%
Sales Q2Q%-38.72%

3.2 Future

GORV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.34% yearly.
Based on estimates for the next years, GORV will show a very strong growth in Revenue. The Revenue will grow by 22.74% on average per year.
EPS Next Y57.47%
EPS Next 2Y43.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.13%
Revenue Next 2Y13.1%
Revenue Next 3Y22.74%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GORV Yearly Revenue VS EstimatesGORV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
GORV Yearly EPS VS EstimatesGORV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

6

4. Valuation

4.1 Price/Earnings Ratio

GORV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 0.94, the valuation of GORV can be described as very cheap.
Based on the Price/Forward Earnings ratio, GORV is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
GORV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE N/A
Fwd PE 0.94
GORV Price Earnings VS Forward Price EarningsGORV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of GORV indicates a rather cheap valuation: GORV is cheaper than 99.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.06
EV/EBITDA N/A
GORV Per share dataGORV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

GORV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GORV's earnings are expected to grow with 43.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.34%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GORV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LAZYDAYS HOLDINGS INC

NASDAQ:GORV (5/23/2025, 8:19:58 PM)

After market: 0.2377 -0.05 (-17.49%)

0.2881

+0.1 (+54.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners95.72%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner Change44.01%
Market Cap31.76M
Analysts82.86
Price Target10.2 (3440.44%)
Short Float %0.87%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.94
P/S 0.04
P/FCF 1.06
P/OCF 0.79
P/B 0.4
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-4.06
EYN/A
EPS(NY)0.31
Fwd EY106.21%
FCF(TTM)0.27
FCFY94.07%
OCF(TTM)0.36
OCFY126.42%
SpS6.96
BVpS0.73
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.91%
ROE -215%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.77%
FCFM 3.9%
ROA(3y)-10.85%
ROA(5y)-3.93%
ROE(3y)-96.04%
ROE(5y)-50.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.14%
GM growth 5Y-2.08%
F-Score5
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 8.06
Debt/EBITDA N/A
Cap/Depr 52.01%
Cap/Sales 1.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.25
Altman-Z 0.87
F-Score5
WACC7.36%
ROIC/WACCN/A
Cap/Depr(3y)281.4%
Cap/Depr(5y)231.34%
Cap/Sales(3y)4.66%
Cap/Sales(5y)3.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.48%
EPS Next Y57.47%
EPS Next 2Y43.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.5%
Revenue growth 3Y-10.97%
Revenue growth 5Y6.21%
Sales Q2Q%-38.72%
Revenue Next Year6.13%
Revenue Next 2Y13.1%
Revenue Next 3Y22.74%
Revenue Next 5YN/A
EBIT growth 1Y-270.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y123.11%
FCF growth 3YN/A
FCF growth 5Y27.91%
OCF growth 1Y148.14%
OCF growth 3Y223%
OCF growth 5Y19.39%